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The compounds 1a-d are novel potential antitumoral 3-(aryl)benzothieno[2,3-c]pyran-1-ones [1]. The 
fluorescence properties of these four compounds were studied in solution and in lipid aggregates of egg 
yolk phosphatidylcholine (Egg-PC), dioctadecyldimethylammonium bromide (DODAB) and dipalmitoyl 
phosphatidylcholine (DPPC). Compound 1c exhibits the largest red shifts in emission with increasing 
solvent polarity (26 nm between cyclohexane and DMSO), together with significantly higher fluorescence 
quantum yields relative to the other compounds. The type and position of the substituents strongly 
influence the photophysical behavior of these molecules in solution. 
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1a R1= F, R2 = H
1b R1= H, R2 = F
1c R1= OMe, R2 = H
1d R1= H, R2 = OMe
 
 
 
  Figure 1 - Normalised fluorescence spectra of compound 1a  
      in lipid membranes of DPPC, Egg-PC and DODAB. 
 
The antitumoral activity of compounds 1a-c was evaluated in three representative human tumor cell lines, 
MCF-7 (breast adenocarcinoma), SF-268 (CNS cancer) and NCI-H460 (non-small cell lung cancer). 
Compound 1b was shown to be the most potent against all the cell lines tested, presenting low GI50 (the 
lowest concentration causing 50% of the cell growth inhibition after a continuous exposure of 48 h) 
values (12-19 µM) [1].  
Fluorescence anisotropy measurements of the compounds incorporated in vesicles of DPPC, Egg-PC and 
DODAB indicate that the four compounds have distinct behaviors in lipid membranes. While compound 
1b is deeply located inside the lipid bilayer, the behaviour of compounds 1a, 1c and 1d point to the 
presence of two different locations in lipid aggregates (fig. 1), one corresponding to molecules located 
near the hydrocarbon tails and the other in a more hydrated and less viscous environment. The deeper 
penetration of compound 1b in lipid membranes can play an important role on the promising antitumoral 
activity of this compound.  
 
Acknowledgements: This work was funded by Foundation for Science and Technology (FCT, Portugal) and FEDER through 
CFUM and CQ-UM, research project PTDC/QUI/81238/2006 and PhD grants of M.S.D. Carvalho SFRH/BD/47052/2008 and 
of R.C. Calhelha SFRH/BD/29274/2006. 
 
References: [1] M.-J.R.P. Queiroz et al., Eur. J. Med. Chem. 44 (2009) 1893. 
